duloxetine hydrochloride has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrick, TR; Howe, FA; Russell, MD; Sofat, N | 1 |
| Binder, EB; Carrillo-Roa, T; Craighead, WE; Dunlop, BW; Kelley, ME; Kutner, MH; Lori, A; Mayberg, HS; Nemeroff, CB; Rivera, VA | 1 |
| Cunningham, EA; Kassam, AS; Musco, SE | 1 |
| Kim, SC; Landon, JE; Solomon, DH | 1 |
| Fasano, A; Morgante, F | 1 |
| Bruno, A; D'Arrigo, C; Mallamace, D; Maria Romeo, V; Mico', U; Muscatello, MR; Pandolfo, G; Spina, E; Zoccali, RA | 1 |
2 trial(s) available for duloxetine hydrochloride and Disease Exacerbation
| Article | Year |
|---|---|
Reduced anterior cingulate grey matter volume in painful hand osteoarthritis.
Topics: Aged; Analgesics; Analysis of Variance; Disease Progression; Double-Blind Method; Duloxetine Hydrochloride; Female; Gray Matter; Gyrus Cinguli; Hand Joints; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteoarthritis; Pain Measurement; Pregabalin | 2018 |
Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antipsychotic Agents; Clozapine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Executive Function; Female; Guidelines as Topic; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2011 |
4 other study(ies) available for duloxetine hydrochloride and Disease Exacerbation
| Article | Year |
|---|---|
Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse.
Topics: Adult; Aged; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cognitive Behavioral Therapy; Depressive Disorder, Major; Disease Progression; Duloxetine Hydrochloride; Female; Humans; Latent Class Analysis; Male; Middle Aged; Receptor, Serotonin, 5-HT2A; Receptors, Kainic Acid; Serotonin Plasma Membrane Transport Proteins; Tacrolimus Binding Proteins; Treatment Outcome; Young Adult | 2018 |
Dangers of Rapid Dosing: A Case of Dose-Dependent Drug-Induced Liver Injury From Duloxetine.
Topics: Adult; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Mental Disorders | 2019 |
Clinical characteristics and medication uses among fibromyalgia patients newly prescribed amitriptyline, duloxetine, gabapentin, or pregabalin.
Topics: Amines; Amitriptyline; Analgesics; Anti-Anxiety Agents; Antidepressive Agents; Cyclohexanecarboxylic Acids; Disease Progression; Duloxetine Hydrochloride; Female; Fibromyalgia; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain Measurement; Pregabalin; Prescription Drugs; Retrospective Studies; Thiophenes; Treatment Outcome | 2013 |
Improvement with duloxetine in primary progressive freezing gait.
Topics: Brain; Disease Progression; Dopamine Uptake Inhibitors; Drug Administration Schedule; Duloxetine Hydrochloride; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Thiophenes | 2010 |